June 9 (Reuters) – Privately held Element Biosciences said on Tuesday it had raised funds in an upsized Series E round, including $175 million from longtime investor Samsung Electronics, to expand
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Israeli whistleblowers detail Gaza civilian toll in Venice film
By Crispian Balmer VENICE, Sept 10 (Reuters) - Mass civilian deaths were routinely built into…
Spain issues permit to allow autonomous vehicle testing, Uber says
MADRID, Sept 10 (Reuters) - Spanish authorities have issued the first national permits to allow…
US to issue $500 Obamacare refunds to nearly a million Americans
WASHINGTON, Sept 10 (Reuters) - Nearly one million Americans enrolled in Obamacare plans will receive…
